Neutrogena Rapid Clear Treatment Pads Salicylic Acid 20 mg Cloth, 60-count
by Kenvue Brands LLC · 60 CLOTH in 1 JAR (69968-0719-6)
NDC 69968-0719-06
🏷️ FDA NDC (as labeled)
69968-0719-6
billing pads the package segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
69968-0719-6
Product NDC
69968-0719
11-digit billing NDC
69968071906
RxCUI
797892
UNII
O414PZ4LPZ
UPC
0070501025901
Application #
M006
SPL Set ID
ec139967-e448-a9cb-e053-2995a90aed6e
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2022-11-10
Route
TOPICAL
Dosage form
CLOTH
Substance
SALICYLIC ACID
Why two NDCs?
The FDA registers this code as 69968-0719-6 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 69968-0719-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Salicylic acid and derivatives class.
Drug family (ATC)
Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerKenvue Brands LLC
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code69968
First marketedNov 2022
Product typeHuman Otc Drug
Portfolio564 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- It's designed to treat acne. Salicylic acid helps by loosening and removing dead skin cells that clog pores — the buildup that leads to breakouts. The multi-step system on this lab...
- What is this salicylic acid product actually supposed to do for my skin?
- Some mild tingling, stinging, and peeling is actually expected — that's the salicylic acid doing its job by clearing away dead skin cells. But if the burning or peeling feels exces...
- My skin feels like it's burning and peeling. Is that normal?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Salicylic Acid?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII F5UM2KM3W7
Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
-
UNII 3XUS85K0RA
Butylene glycol is a clear liquid derived from petroleum or plants that acts as a humectant, solvent, and preservative booster in medicines. It helps keep formulations stable, dissolve active ingredients, and maintain moisture in topical products.
-
UNII GC844VRD7E
A synthetic fatty acid ester derived from plant oils and lactic acid. It acts as an emulsifier and solvent to help mix oil and water-based ingredients and improve how the medicine dissolves or spreads in the body.
-
UNII A7EVH2RK4O
Cetyl lactate is a waxy compound made from lactic acid and cetyl alcohol. It works as an emulsifier and thickener to help mix oil and water ingredients and give the medicine the right texture.
-
UNII H2KVQ74JM4
A compound derived from coconut oil that acts as a conditioning agent and surfactant. It helps stabilize and thicken liquid formulations while reducing static and improving texture in topical products.
-
UNII 8NLQ36F6MM
Edetate disodium anhydrous is a chemical compound that binds to metal ions in a medicine. It's used as a stabilizer to prevent unwanted chemical reactions and help keep the drug product effective during storage.
-
UNII PWZ7N4UIKE
A silicone-based ingredient that combines polyethylene glycol, polypropylene glycol, and dimethicone. It acts as a lubricant, emulsifier, and anti-foaming agent to improve how the medicine flows and mixes during manufacturing.
-
UNII 4AAN25P8P4
A synthetic liquid derived from propylene glycol and cetyl alcohol, used as an emulsifier and solubilizer to help mix oil and water-based ingredients and keep the medicine uniform throughout.
-
UNII 1Q73Q2JULR
Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
-
UNII 55X04QC32I
A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
12 inactive ingredients listed in the exact product block matched to this NDC.
The official label also stateswater, alcohol denat., butylene glycol, PPG-5-ceteth-20, C12-15 alkyl lactate, sodium citrate, cocamidopropyl PG-dimonium chloride phosphate, fragrance, PEG/PPG-20/6 dimethicone, sodium hydroxide, benzalkonium chloride, cetyl lactate, disodium EDTA
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Stridex Maximum 2 g/100mL 10157-1006-01 | Blistex | 1 jar | — | — | FDA listed | — |
| Stridex XL Face and Body Pads 2 g/100mL 10157-2114-01 | Blistex | 1 jar | — | — | FDA listed | — |
| OXY ADVANCED CARE 3 in 1 RETEXTURIZING CLEANSING PADS 20 mg 10742-1000-01 | The | 90 swabs | — | — | FDA listed | — |
| Oxy Deep Pore Acne Cleansing Pads 20 mg 10742-1006-01 | The | 90 cloths | — | — | FDA listed | — |
| Oxy 3-IN-1 Acne Cleansing Pads 20 mg 10742-1008-01 | The | 90 cloths | — | — | FDA listed | — |
| Oxy 3-IN-1 Acne Cleansing Pads 20 mg 10742-1010-01 | The | 90 fors | — | — | FDA listed | — |
| Oxy Deep Pore Acne Cleansing Pads 20 mg 10742-1011-01 | The | 90 fors | — | — | FDA listed | — |
| OXY ADVANCED CARE MAXIMUM STRENGTH 3-in-1 ACNE PADS 20 mg 10742-1200-01 | The | 90 swabs | — | — | FDA listed | — |
| OXY Deep Pore Cleansing Pads 20 mg 10742-4204-01 | The | 90 swabs | — | — | FDA listed | — |
| OXY 3 in 1 Acne Pads 20 mg 10742-4359-01 | The | 90 swabs | — | — | FDA listed | — |
| Proactiv CLEAR ZONE BODY PADS 2 g/100mL 11410-0056-00 | Alchemee, | 75 applicators | — | — | FDA listed | — |
| ZO Skin Health Oil Control Pads Acne Treatment 20 mg/mL 42851-0085-30 | ZO | 30 patches | — | — | FDA listed | — |
| Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Pads 20 mg/mL 49967-0705-01 | L'Oreal | 60 applicators | — | — | FDA listed | — |
| Gly-Sal 5-2 Pads .02 g 51326-0038-60 | Topiderm, | 60 cloths | — | — | FDA listed | — |
| Gly-Sal 10-2 Pads .02 g 51326-0039-60 | Topiderm, | 60 cloths | — | — | FDA listed | — |
| Gly-Sal 10-2 20 mg 51326-0712-60 | Topiderm, | 60 cloths | — | — | FDA listed | — |
| Gly-Sal 2-2 Pads 20 mg 51326-0923-01 | Topiderm, | 60 cloths | — | — | FDA listed | — |
| Max Complexion Correction Pads 2 g/100mL 54031-0501-22 | PETER | 60 patches | — | — | FDA listed | — |
| Equate Beauty Quick Action Pads Salicylic Acid Acne Treatment 20 mg/mL 61805-0117-01 | Bath | 90 patches | — | — | FDA listed | — |
| DermaClear Pads 20 mg/g 62742-4076-02 | Allure | 1 jar | — | — | FDA listed | — |
| Universal Clarifying Pad 20 mg/g 62742-4276-02 | Allure | 1 jar | — | — | FDA listed | — |
| Clearasil Rapid Rescue Deep Treatment Pads .02 g 63824-0431-90 | Reckitt | 90 cloths | — | — | FDA listed | — |
| Noxzema ANTIBLEMISH .02 g/g 64942-1259-01 | Conopco | 0284 g | — | — | FDA listed | — |
| Rush Salicylc Acid Complexion Pads 2 g/100g 65113-1201-01 | G.S. | 1 jar | — | — | FDA listed | — |
| Anti-Aging Blemish Control Peel Pads 2.366 g/118.29g 65278-0318-01 | June | 118.29 g | — | — | FDA listed | — |
| Neutrogena Rapid Clear Treatment Pads 20 mgthis 69968-0719-06 | Kenvue | 60 cloths | — | — | FDA listed | — |
| Retexturizing Body Pads 2 g/100mm 70381-0126-02 | Murad, | 1 jar | — | — | FDA listed | — |
| Cleansing Wipes 2 g/100mL 71613-0001-01 | Nextcell | 25 applicators | — | — | FDA listed | — |
| FHF Change Peel Pads 2 g/100g 72788-0183-02 | Summer | 1 bottle | — | — | FDA listed | — |
| Acne Correction Pads 2 g/100mL 72957-0012-01 | Private | 1 jar | — | — | FDA listed | — |
| AHA/BHA Swipes 2 g/100mL 73318-7004-06 | SKIN | 1 jar | — | — | FDA listed | — |
| ESSENCE BY CATHERINE HINDS PURIFYING PADS with 2% Salicylic Acid 2 g/100mL 76446-0022-50 | Anna | 1 jar | — | — | FDA listed | — |
| anna lotan PURIFYING PADS with 2% Salicylic Acid 2 g/100mL 76446-0039-50 | Anna | 1 jar | — | — | FDA listed | — |
| Equate 2% Salicylic acid Acne treatment pad 2 g/100g 79903-0062-01 | Walmart, | 165 g | — | — | FDA listed | — |
| Maximum Sterngth Cleansing Pads Equate 2 g 79903-0207-01 | Walmart | 1 jar | — | — | FDA listed | — |
| Tingl Exfoliating Pads 2 g/100g 83286-0011-01 | Drmtlgy, | 60 patches | — | — | FDA listed | — |
| Crystal Clear Acne Treatment Pads 2 g/100mL 83316-0001-01 | Skin | 60 patches | — | — | Discontinued | — |
| First Aid Beauty Acne Clearing Pads 2 g/100mL 84126-0119-60 | The | 60 patches | — | — | FDA listed | — |
| Tula Skincare Breakout Breakthrough Acne Toner Pads 2 g/1001 84126-0152-30 | The | 1 jar | — | — | FDA listed | — |
| Acne Treatment Cotton Pads 2 g/100g 84356-0003-01 | Guangzhou | 100 g | — | — | FDA listed | — |
| Societe Clear Skin Pads 2 g/100g 87700-0147-02 | Societe | 1 jar | — | — | FDA listed | — |
| Dr. Zenovia Clear Complexion 20 mg 51326-0801-01 | Topiderm, | 1 bottle | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2022
On the market since
Nov 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Neutrogena Rapid Clear Treatment Pads (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 37%
Female · 63%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 69968-0719-06 You're viewing this | 60 CLOTH in 1 JAR (69968-0719-6) | 2022-11-10 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 69968-0719-6, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 69968-0719-06, written without dashes as 69968071906. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 69968-0719-06, the first segment (69968) is the labeler code FDA assigned to Kenvue Brands LLC; the middle segment (0719) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (06) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Kenvue Brands LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Kenvue Brands LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings and Cautions
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use For the treatment of acne.
⏱️ Dosage and Administration ▾
Directions • cleanse skin thoroughly before applying this product • cover the entire affected area with a thin layer one to three times daily • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
⚠️ Warnings and Cautions ▾
Flammable Flammable – Keep away from fire or flame.
⚠️ Warnings ▾
Warnings For external use only. Flammable Flammable – Keep away from fire or flame. When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. • if eye contact occurs, flush thoroughly with water. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information Store at Room Temperature. Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing and limit sun exposure while using this product and for a week afterwards.
🧪 Active Ingredient ▾
Active ingredient Salicylic Acid 2%
🧪 Inactive Ingredients ▾
Inactive ingredients water, alcohol denat., butylene glycol, PPG-5-ceteth-20, C12-15 alkyl lactate, sodium citrate, cocamidopropyl PG-dimonium chloride phosphate, fragrance, PEG/PPG-20/6 dimethicone, sodium hydroxide, benzalkonium chloride, cetyl lactate, disodium EDTA
🎯 Purpose ▾
Purpose Acne medication
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.